Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441568A1 Pharmaceutical combinations for the treatment of cancer
10/03/2002CA2441484A1 Molecular conjugates for use in treatment of cancer
10/03/2002CA2441455A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002CA2441412A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
10/03/2002CA2441394A1 Agents and methods for treatment of cancer
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441377A1 Protein phosphate inhibitors
10/03/2002CA2441228A1 Combination treatment of pancreatic cancer
10/03/2002CA2441227A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2440713A1 Nicotine-containing oral dosage form
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2440322A1 Oligonucleotide conjugates
10/03/2002CA2440040A1 One-step process for preparing chewing gum
10/03/2002CA2439676A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2436198A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof
10/03/2002CA2434691A1 Use of propentofylline to control intraocular pressure
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002CA2410469A1 Improved forms of pharmaceutically active agents and method for manufacture thereof
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/03/2002CA2405453A1 Pharmaceutical composition containing camptothecin derivative and ph-adjusting substance
10/02/2002WO2001076587A1 Remedies for diseases due to stenotic lesions of blood vessel
10/02/2002EP1245681A2 A method for the production of pharmaceutically active recombinant proteins comprising the use of alkanoic acids, their derivatives or salts thereof
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245583A1 Food product with sustained energy release
10/02/2002EP1245580A1 Fibre containing composition for enteral nutrition
10/02/2002EP1245572A1 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245567A1 HIV inhibiting pyrimidine derivatives
10/02/2002EP1245566A1 Quinolin-4-one derivatives and their use as antibiotics
10/02/2002EP1245565A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/2002EP1245564A1 Benzamidine derivatives
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245561A1 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002EP1245233A1 System for stabilizing lacrimal fluid layer
10/02/2002EP1245232A1 Oral solid preparation
10/02/2002EP1245231A2 Pharmaceutical formulations containing darifenacin
10/02/2002EP1245230A2 Amentoflavone as an antiviral agent
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1245228A2 Medicament for the inducement of cognition enhancement
10/02/2002EP1244916A1 INHIBITION OF $g(b)ARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244781A2 Antisense oligonucleotides
10/02/2002EP1244778A2 Human heparanase-related polypeptide and nucleic acid
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244725A2 Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom
10/02/2002EP1244698A2 Novel human transporter proteins and polynucleotides encoding the same
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244679A1 Purine derivatives
10/02/2002EP1244678A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244677A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244673A2 Novel imidazo 1,3,5]triazinones and the use thereof
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244671A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors
10/02/2002EP1244670A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244668A1 Purine derivatives, process for their preparation and use thereof
10/02/2002EP1244667A2 Cyclohexene nucleic acids
10/02/2002EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives
10/02/2002EP1244664A1 Compounds and methods for the treatment of pain
10/02/2002EP1244663A1 Compounds and methods for the treatment of pain
10/02/2002EP1244662A1 Compound and method for the treatment of pain
10/02/2002EP1244661A1 Compounds and methods for the treatment of pain
10/02/2002EP1244660A1 Methods and compositions for the treatment of pain
10/02/2002EP1244659A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors
10/02/2002EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244654A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244652A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244650A1 Arylamine derivatives and their use as anti-telomerase agent
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244640A1 Oxazolidinone derivatives
10/02/2002EP1244639A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
10/02/2002EP1244637A1 Butyne diol derivatives
10/02/2002EP1244636A1 Benzimidazoles, production thereof and the use thereof as antithrombotic
10/02/2002EP1244631A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10/02/2002EP1244630A1 Amphiphilic polyamines, the use and method for synthesis thereof
10/02/2002EP1244629A2 Quinolone compounds for use in treating viral infections
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244627A1 Picolinic acid derivatives and their use as fungicides
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines
10/02/2002EP1244624A1 Anthracene derivatives as anti-cancer agents
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
1 ... 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 5704 5705 5706 5707 5708 5709 5710 5711 5712 ... 7860